EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Autophagy Inhibition by Fangji Huangqi Decoction Enhances Tumor Immunogenicity and Potentiates PD ‐1 Blockade

Yuxiao Jiang, Shiji Zeng, Dingye Wang, Junbo Jiang, Zhenzhen Li, Jingbi Li, Dan Chen, Xu Zhao, Zheng Ying, Yuehua Deng, Qianwei Cai, Silin Mai und 7 weitere

Cancer Science · 2026

DOI: 10.1111/cas.70399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2026. Verfasst von Yuxiao Jiang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Immunomodulating Agents, Melanoma, Experimental, Carcinoma, Lewis Lung. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the Research Special Fund for the High-Level Hospital Co-Construction Project between Guangzhou University of Chinese Medicine and Zhongshan Traditional Chines…, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fangji Huangqi Decoction (FJHQ), a traditional Chinese medicine formula derived from “Jin Gui Yao Lue,” has been reported to exhibit immunomodulatory and anti‐inflammatory effects. This study investigates its potential anti‐tumor mechanism via the enhancement of CD8 + T cell‐mediated immunity. In murine B16 melanoma and Lewis lung carcinoma models, FJHQ significantly suppressed tumor growth and enhanced CD8 + T cell infiltration and cytotoxicity. CD8 + T cell depletion abrogated these effects, confirming their necessity. In vitro, FJHQ treatment augmented antigen presentation by tumor cells through upregulation of MHC‐I expression, leading to improved CD8 + T cell recognition and killing. Mechanistically, FJHQ inhibited autophagic flux in tumor cells, as evidenced by mCherry‐GFP‐LC3 reporter assays and electron microscopy, resulting in impaired lysosomal function and elevated MHC‐I levels. Furthermore, combining FJHQ with anti–PD‐1 therapy synergistically promoted CD8 + T cell activity, increased granzyme B and IFN‐γ expression, and induced substantial tumor regression. These findings demonstrate that FJHQ enhances antitumor immunity by suppressing autophagy and elevating MHC‐I expression, thereby sensitizing tumors to PD‐1 blockade. FJHQ represents a promising immunoadjuvant for cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalImmunomodulating AgentsMelanoma, ExperimentalCarcinoma, Lewis LungImmune Checkpoint InhibitorsAutophagyDrug SynergismCD8-Positive T-LymphocytesAnimalsMiceProgrammed Cell Death 1 ReceptorAntineoplastic Combined Chemotherapy ProtocolsAntigen PresentationHistocompatibility Antigens Class IGene Expression Regulation, NeoplasticGranzymesInterferon-gammaA549 CellsHumansMale

Stichwörter der Autor:innen

Fangji Huangqi DecoctionCD8+ T cellsMHC‐I antigen presentationPD‐1 blockadeautophagy inhibitiontumor immunity

Substanzen

huangqi decoctionDrugs, Chinese HerbalImmunomodulating AgentsProgrammed Cell Death 1 ReceptorImmune Checkpoint InhibitorsHistocompatibility Antigens Class IGranzymesInterferon-gamma

Autor:innen und Institutionen

  • Research Center of Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Department of Biochemistry, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Department of Pathology and Pathophysiology, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Zhongshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Chinese Medicine, Zhongshan, China.
  • School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Department of Human Anatomy, Guangzhou University of Chinese Medicine, Guangzhou, China.

ORCID-Profile: Kun Wang

Förderung

  • the Research Special Fund for the High-Level Hospital Co-Construction Project between Guangzhou University of Chinese Medicine and Zhongshan Traditional Chines…
  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province
  • Science and Technology Plan Project of Guangzhou, China

Zitieren

APA

Jiang, Y., Zeng, S., Wang, D., Jiang, J., Li, Z., Li, J., Chen, D., Zhao, X., Ying, Z., Deng, Y., Cai, Q., Mai, S., Zheng, J., Yang, Q., Liu, F., Du, B., Xiao, J., Liu, X., & Wang, K. (2026). Autophagy Inhibition by Fangji Huangqi Decoction Enhances Tumor Immunogenicity and Potentiates PD ‐1 Blockade. Cancer Science. https://doi.org/10.1111/cas.70399

Vancouver

Jiang Y, Zeng S, Wang D, Jiang J, Li Z, Li J, et al. Autophagy Inhibition by Fangji Huangqi Decoction Enhances Tumor Immunogenicity and Potentiates PD ‐1 Blockade. Cancer Science. 2026. doi:10.1111/cas.70399

BibTeX
@article{Jiang2026,
  author = {Jiang, Yuxiao and Zeng, Shiji and Wang, Dingye and Jiang, Junbo and Li, Zhenzhen and Li, Jingbi and Chen, Dan and Zhao, Xu and Ying, Zheng and Deng, Yuehua and Cai, Qianwei and Mai, Silin and Zheng, Jiayi and Yang, Qiaohong and Liu, Fang and Du, Biaoyan and Xiao, Jianyong and Liu, Xiaoyi and Wang, Kun},
  title = {Autophagy Inhibition by Fangji Huangqi Decoction Enhances Tumor Immunogenicity and Potentiates PD ‐1 Blockade},
  journal = {Cancer Science},
  year = {2026},
  doi = {10.1111/cas.70399}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche